Patents by Inventor Yasumi Nishiwaki

Yasumi Nishiwaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adsorbents for oral administration
    Patent number: 9682046
    Abstract: The present invention aims to provide an adsorbent for oral administration comprising ACF that has high adsorption or removal performance by adsorbing or removing toxic substances in the living body greatly and rapidly. The present invention is an adsorbent for oral administration comprising activated carbon fibers for treating or preventing kidney diseases or dialysis complications.
    Type: Grant
    Filed: October 5, 2012
    Date of Patent: June 20, 2017
    Assignee: Teijin Pharma Limited
    Inventors: Yasumi Nishiwaki, Takashi Murakami, Nobuaki Eto, Keiichiro Imaizumi, Akihito Ohtaki, Kenji Shimazaki
  • ADSORBENTS FOR ORAL ADMINISTRATION
    Publication number: 20140242147
    Abstract: The present invention aims to provide an adsorbent for oral administration comprising ACF that has high adsorption or removal performance by adsorbing or removing toxic substances in the living body greatly and rapidly. The present invention is an adsorbent for oral administration comprising activated carbon fibers for treating or preventing kidney diseases or dialysis complications.
    Type: Application
    Filed: October 5, 2012
    Publication date: August 28, 2014
    Applicant: TEIJIN PHARMA LIMITED
    Inventors: Yasumi Nishiwaki, Takashi Murakami, Nobuaki Eto, Keiichiro Imaizumi, Akihito Ohtaki, Kenji Shimazaki
  • 1-BIARYLAZETIDINONE DERIVATIVE
    Publication number: 20100125059
    Abstract: The object of the present invention is to provide a compound having an excellent cholesterol-lowering effect and to provide a drug for the treatment, prevention of onset, or prevention of progress of lipid metabolism disorder, hyperlipidemia, or atherosclerosis. A compound represented by formula (I) or a pharmaceutically acceptable salt thereof; or a medicament or a pharmaceutical composition, which contain the compound or the salt as an active ingredient.
    Type: Application
    Filed: March 4, 2008
    Publication date: May 20, 2010
    Applicant: Teijin Pharma Limited
    Inventors: Akira Nakano, Ryota Nakajima, Masanobu Kanou, Seiichi Hisamatsu, Masayuki Kurokawa, Yasumi Nishiwaki